Patients with BRAF V600E-mutant CRC are more likely to develop extensive peritoneal metastases than liver-limited metastases, are less likely to undergo resection surgery, and have a higher risk of postoperative recurrence [6]. The gene discussed is BRAF; the disease is colorectal carcinoma.